Intuitive Surgical, Inc. (NASDAQ:ISRG) is Robocap Asset Management Ltd's 10th Largest Position

Robocap Asset Management Ltd cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 18.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,035 shares of the medical equipment provider's stock after selling 2,725 shares during the period. Intuitive Surgical accounts for approximately 4.5% of Robocap Asset Management Ltd's portfolio, making the stock its 10th largest position. Robocap Asset Management Ltd's holdings in Intuitive Surgical were worth $5,961,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Atala Financial Inc purchased a new stake in Intuitive Surgical in the fourth quarter worth about $25,000. Hurley Capital LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth about $28,000. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth about $26,000. Chilton Capital Management LLC lifted its holdings in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares during the period. Finally, Global Financial Private Client LLC lifted its holdings in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after buying an additional 38 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have commented on ISRG. Citigroup restated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Barclays dropped their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Finally, Evercore ISI boosted their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $592.59.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $13.99 during mid-day trading on Friday, reaching $512.06. The stock had a trading volume of 2,951,229 shares, compared to its average volume of 1,679,961. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The stock has a market cap of $183.53 billion, a PE ratio of 75.08, a price-to-earnings-growth ratio of 5.58 and a beta of 1.64. The company has a fifty day moving average price of $537.85 and a 200 day moving average price of $536.69.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the business earned $1.50 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director directly owned 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president owned 5,224 shares of the company's stock, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 in the last quarter. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.